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Abstract
We have developed an implantable fuel cell that generates power through glucose oxidation, producing 3:4 mWc m {2
steady-state power and up to 180 mWc m {2 peak power. The fuel cell is manufactured using a novel approach, employing
semiconductor fabrication techniques, and is therefore well suited for manufacture together with integrated circuits on a
single silicon wafer. Thus, it can help enable implantable microelectronic systems with long-lifetime power sources that
harvest energy from their surrounds. The fuel reactions are mediated by robust, solid state catalysts. Glucose is oxidized at
the nanostructured surface of an activated platinum anode. Oxygen is reduced to water at the surface of a self-assembled
network of single-walled carbon nanotubes, embedded in a Nafion film that forms the cathode and is exposed to the
biological environment. The catalytic electrodes are separated by a Nafion membrane. The availability of fuel cell reactants,
oxygen and glucose, only as a mixture in the physiologic environment, has traditionally posed a design challenge: Net
current production requires oxidation and reduction to occur separately and selectively at the anode and cathode,
respectively, to prevent electrochemical short circuits. Our fuel cell is configured in a half-open geometry that shields the
anode while exposing the cathode, resulting in an oxygen gradient that strongly favors oxygen reduction at the cathode.
Glucose reaches the shielded anode by diffusing through the nanotube mesh, which does not catalyze glucose oxidation,
and the Nafion layers, which are permeable to small neutral and cationic species. We demonstrate computationally that the
natural recirculation of cerebrospinal fluid around the human brain theoretically permits glucose energy harvesting at a rate
on the order of at least 1 mW with no adverse physiologic effects. Low-power brain–machine interfaces can thus potentially
benefit from having their implanted units powered or recharged by glucose fuel cells.
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Introduction
As implantable electronic devices become increasingly prevalent
in the diagnosis, management, and treatment of human disease,
there is a correspondingly increasing demand for devices with
unlimited functional lifetimes that integrate seamlessly into their
host biological systems. Consequently, a holy grail of bioelectronics
is to engineer biologically implantable systems that can be
embedded without disturbing their local environments while
harvesting from their surroundings all of the power they require.
In particular, micropower implantable electronics beg the question
of whether such electronics can be powered from their surround-
ing tissues. Here we discuss how to construct an implantable
glucose fuel cell suitable for such applications, and how it may
potentially be powered from cerebrospinal fluid in the brain.
Bioimplantable Power Sources
Various solutions to the problem of providing power to
biologically implanted devices have been proposed, prototyped,
or implemented. Two principal solutions are currently in
widespread use: single-use batteries, such as those used in
implantable pulse generators for cardiac pacing, defibrillation,
and deep brain stimulation, which are designed to have finite
lifetimes and to be replaced surgically at intervals of several years
[1]; and inductive power transfer, typically accomplished transcu-
taneously at radio frequencies, as in cochlear implants [2,3].
Inductive schemes can be used either to supply power continu-
ously or to recharge an implanted power source. Recent advances
in battery technology and related fields, leading to increased
energy and power densities in small devices such as super-
capacitors [4,5] as well as thin film lithium and thin film lithium
ion batteries [6], will facilitate improvements in systems based on
these two solutions, particularly by shrinking battery sizes and
extending battery lifetimes.
Power Scavenging and Power Requirements for
Implantable Electronics
Systems for transducing light [7], heat [8], mechanical vibration
[9], as well as near- [3,10] or far-field [11] electromagnetic
radiation, into electrical energy, have been described and
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38436implemented. Several of these energy-harvesting techniques, as
well as electronic design techniques required to make use of them,
have been discussed in depth in [12,13]. Here we focus on
powering biologically implanted devices by harvesting energy from
glucose in the biological environment.
The emergence of ultra-low-power bioelectronics as a field over
the last decade [13] has led to the development of highly energy-
efficient, implantable medical devices with power budgets in the
microwatt regime. This new generation of low-power devices has
driven interest in a range of sustainable power sources and energy
scavenging systems that, while impractical for conventionally
designed electronic devices, are entirely practical in the context of
micropower electronics [13]. For example, in brain– machine
interfaces, the combination of low-power circuit design [14] and
adaptive power biasing [15] can be used to build sub-microwatt
neural amplifiers for multi-electrode arrays. Impedance-modula-
tion radio-frequency (RF) telemetry techniques can drastically
reduce implanted-unit power consumption and operate at less
than 1 nJ bit{1 even for transcutaneous data rates as high as
3 Mbps in brain– machine interfaces. Finally, ultra-low-power
analog processing techniques [13,16] can enable 100-channel
neural decoding at micropower levels [17,18] and dramatically
reduce the data rates needed for communication, further reducing
total power consumption. The combination of these advances in
energy-efficient amplification, communication, and computation
implies that implanted components in brain– machine interfaces
that operate with tens of microwatts of total power consumption
are feasible today. Therefore, implantable biofuel cells such as the
one presented here, which generate power at densities on the
order of 1–100 mWc m 2, provide useful power sources for such
ultra-low-power implantable medical devices.
Glucose Fuel Cells
A fuel cell generates power by catalyzing complementary
electrochemical reactions (oxidation and reduction) at a pair of
corresponding electrodes (the anode and cathode, respectively), as
a reducing-agent fuel flows across the anode and an oxidant flows
across the cathode. The fuel substrate is electrooxidized at the
anode, which collects the liberated electrons and conducts them
through an external load to the cathode. Typically an ion-selective
membrane partitions the anode and cathode into separate
chambers, facilitating a unidirectional flow of protons, generated
via oxidation at the anode, to the cathode. The protons arriving at
the cathode through the solution, the electrons arriving at the
cathode through the external circuit, and the oxidant at the
cathode undergo a redox reaction that reestablishes charge
neutrality in the overall cell.
One approach to harvesting energy from a physiologic
environment is to extract it from physiologically available
biological fuel substrates such as glucose. In a glucose-based
biofuel cell, glucose is oxidized at the anode, while oxygen is
reduced to water at the cathode. The nature of the catalyst
residing at the anode determines the extent of glucose oxidation
and the associated oxidation products. Three major design
paradigms for glucose-based fuel cells have been described,
differing principally in the materials used to catalyze electrode
reactions: In one paradigm the catalysts are abiotic, solid-state
materials; in the second paradigm the catalysts are isolated
enzymes fixed to electrode substrates; and in the third paradigm
oxidation is performed by exoelectrogenic bacterial biofilms
colonizing a fuel cell anode. Numerous designs representing each
of these fuel cell paradigms have been described and reviewed in
the scientific and patent literatures. An extensive review of the
scientific and patent literatures on abiotic implantable glucose fuel
cells is provided in [19]. Bioimplantable fuel cells based on
enzymatic catalysis are reviewed in [20]. Microbial fuel cells are
reviewed in [21].
These three principal catalytic schemes yield systems that differ
markedly from one another in efficiency and robustness.
Enzyme-based glucose fuel cells have high catalytic efficiency,
which together with their small size results in high volumetric
power density, yielding up to 8:3 mA, and 4:3 mW of total power,
in systems with footprints on the order of 1 mm
2 and volumes less
than 10
–2 mm
3 [20]. Such fuel cells are often constructed as
tethered-enzyme systems, in which oxidation and reduction of fuel
cell substrates are catalyzed ex vivo by enzymes molecularly wired
to threads of conductive material. Enzyme-based glucose fuel cells
described in the recent literature have typically generated on the
order of 100 mWc m
22 [22,23]. Fuel cells of this kind may be
capable of continuous operation for up to several weeks, but their
lifetimes are limited by the tendency of enzymes to degrade and
ultimately degenerate with time.
Using living microorganisms, such as exoelectrogenic bacteria,
to catalyze the anodic reaction results in complete oxidation of
glucose, liberating twenty-four electrons per molecule of glucose
consumed. Microbial fuel cells are thus very efficient catalytically,
and can produce more than 1300 mAc m
22 and 1900 mWc m
22
[24,25]. Moreover, in contrast with enzymatic systems, which
have short lifetimes limited by the degradation of tethered
enzymes ex vivo, microbial fuel cells are inherently self-regenerat-
ing: they use a fraction of input biomass to power and supply
molecular substrates for maintenance functions such as resynthesis
of degraded enzymes [21]. Microbial glucose fuel cells described in
the recent literature have typically generated on the order of
1000 mWc m
22 [22,23,26]. However, microbial fuel cells of the
present generation are not yet suitable for biologically implanted
applications. The prospect of implanting even nonpathogenic
bacteria raises concerns of safety and biocompatibility.
Solid-state anode catalysts such as those we use in the work
described here are capable of oxidizing glucose to gluconic acid,
liberating one pair of electrons, and yielding further oxidation
products with reduced probability [19,27]. As a result, they
represent the least catalytically efficient of the three design
paradigms we consider. Yet while glucose fuel cells based on
solid-state catalysts typically only generate on the order of 1–
10 mAc m
22 and 1–10 mWc m
22 [19], they have proven reliable
as implantable power sources for many months [28,29].
Cerebrospinal Fluid as a Physiologic Niche Environment
for a Fuel Cell
An innovation in the work described here is the use of
cerebrospinal fluid as a physiologic niche for an implantable power
source. Implantable fuel cells have typically been designed for use
in blood or interstitial fluid; to the best of our knowledge, the
operation of a biofuel cell in the cerebrospinal fluid has not
previously been described (we are aware of one incidental
reference, made in [30]). The cerebrospinal fluid represents a
promising environment for an implantable fuel cell: It is virtually
acellular, it is under minimal immune surveillance, it has a
hundred-fold lower protein content than blood and other tissues
and is therefore less prone to induce biofouling of implanted
devices, and its glucose levels are comparable to those of blood and
other tissues [31]. The bioavailability of glucose and oxygen to a
fuel cell residing in the subarachnoid space is addressed in detail in
the Methods subsection entitled ‘Brain and Cerebrospinal Fluid as
Sites for an Energy-Harvesting Fuel Cell.’
Glucose Fuel Cells for Brain-Machine Interfaces
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A variety of mechanical designs for bioimplantable biofuel cells
have been described in a literature spanning at least half a century
[19]. A number of physical, electronic, and electrochemical factors
also influence the voltage and current output of a biofuel cell.
These include fuel cell and electrode geometry; electrode and
membrane spacings; redox potentials of fuel cell components;
internal and load impedances; and environmental conditions in
which the cell operates, including fuel substrate concentration,
environmental temperature and pH, and the presence of chemical
species capable of driving parasitic side reactions. Many of these
aspects of fuel cell design have been modeled in detail and
measured empirically in real systems [32,33]. As described in the
Methods Section and as shown in Figures 1, 2, and 3, the novel
design and manufacturing process we describe here is a version of
a classic half-open, two-chamber design [19,34,35], sized and
shaped to fit a particular anatomic compartment, and constructed
using semiconductor fabrication techniques that could in principle
permit manufacture together with integrated circuits on a single
silicon wafer.
Structure of This Paper
This paper is structured as follows. In the Results and
Discussion Section we describe the performance of our glucose
fuel cell. In the Methods Section we address several topics in
detail. First, we discuss solid-state catalysis of glucose oxidation
from a theoretical perspective, and explain the operating principles
of our fuel cell, including its mechanism of separating the
oxidation and reduction reactions, even though their reactants,
glucose and oxygen, naturally occur mixed in physiologic
compartments. Next, we describe our CMOS-compatible process
for fabricating implantable glucose fuel cells. In that subsection we
also describe our approach to characterizing the materials and
electrochemical properties, as well as the power-generating
performance of the fuel cells. We then discuss the power available
from circulating glucose in human physiologic compartments, and
the suitability of the cerebrospinal fluid as a physiologic niche for
power harvesting. We describe a detailed model of glucose and
oxygen consumption by a fuel cell implanted in the subarachnoid
space surrounding the human brain, and analyze the impact of
such a fuel cell on glucose and oxygen homeostasis.
Results and Discussion
Device Characterization
Anode surface roughness by scanning electron
microscopy. The efficiency of the fuel cell critically depends
on its ability to catalyze the oxidation of glucose at the anode. Our
device uses a solid-state platinum anode catalyst, whose catalytic
capacity is directly related to the number of atomic sites it can
provide on its surface. We describe a CMOS-compatible process
for electrode surface roughening to increase effective electrode
surface area, and hence catalytic capacity, in the Methods Section.
Figure 1. Power Extraction from Cerebrospinal Fluid by an Implantable Glucose Fuel Cell. Conceptual schematic design for a system that
harvests power from the cerebrospinal fluid, showing a plausible site of implantation within the subarachnoid space. The inset at right is a
micrograph of one prototype, showing the metal layers of the anode (central electrode) and cathode contact (outer ring) patterned on a silicon
wafer. Image Credit: Meninges and Vascular Anatomy courtesy of the Central Nervous System Visual Perspectives Project, Karolinska Institutet and Stanford
University.
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then reactively etching away all of the aluminum, we generate a
high-surface-area anode with a nanostructure very different from
that of atomically smooth platinum. Here, we illustrate the effects
of that roughening procedure in a series of micrographs. Figure 4
shows the contrast between atomically smooth and roughened
Figure 2. General Operational Scheme for an Implantable Glucose Fuel Cell. This schematic conceptually illustrates the structure of an
abiotically catalyzed glucose fuel cell, including the essential half-cell and overall reactions, the sites at which they occur within the system, and the
flows of reactants and products.
doi:10.1371/journal.pone.0038436.g002
Figure 3. Glucose Fuel Cell in Cross Section. This schematic cross-section of the glucose fuel cell illustrates the structure of the device, as well as
the oxygen and glucose concentration gradients crucially associated with its cathode and anode half-cell reactions, and underlying their respective
site specificity.
doi:10.1371/journal.pone.0038436.g003
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substrate, as seen under optical microscopy. Figure 5 shows a
series of scanning electron micrographs, taken at increasing
magnifications (from single-micrometer to single-nanometer reso-
lution), and showing the persistence of pore-like structures at every
scale, as expected on removing one element of a bimetallic alloy.
The scanning electron micrographs in Figure 6 demonstrates the
contrast between atomically smooth platinum and roughened
platinum at the nanometer scale.
Anode surface roughness by atomic force
microscopy. We used atomic force microscopy to quantify
the surface area enhancements generated by the anode roughen-
ing procedure we employed, using a high-aspect-ratio silicon
nitride probe with radius of curvature 5 nm. Figure 7 shows two
pairs of surface scans, contrasting atomically smooth platinum
with roughened platinum at 10 mm and 1 mm resolution. While
this technique is limited both by the geometry of the scanning
probe and by the single-axis nature of the measurements, variance
in surface height nevertheless provides a quantitative means of
assessing surface roughness. Sampling at 256 sites over 10–mm-
square patches, we measured a variance of 10.3 nm in the
roughened anodes, as compared with a variance of 1.2 nm in
atomically smooth platinum (an 8.5-fold increase in vertical-, or z-
roughness).
Biocompatibility. As we note elsewhere, the cerebrospinal
fluid represents a promising niche for an implantable fuel cell in
that it is virtually acellular and has a hundred-fold lower protein
content than blood and other tissues, so is therefore less prone to
induce biofouling of implanted devices; in addition, it is relatively
free from immune surveillance, and its glucose levels are
comparable to those of blood and other tissues [31].
Furthermore, Nafion is biocompatible [36], and in using it as an
outermost layer encapsulating our fuel cell we enhance the
biocompatibility of the entire device. Moreover, as a cation-
selective ionomer, Nafion is impermeable to negatively charged
proteins, small molecules, and ions, that are present in the
physiologic environment and are known to cause fouling of
catalytic electrodes. Nafion encapsulation has been used in the
context of glucose sensors to increase the functional lifetimes of
implanted electrodes [37].
While the designs described here are intended to optimize
biocompatibility, we note that in evaluating these designs,
biocompatibility must ultimately be assessed in the challenging
context of in vivo testing.
Power Output and Electrochemical Characterization
Equation 3 indicates that our system liberates 2 electrons per
glucose molecule oxidized. In the fuel cell system, the reactions
described in Equation 3 occur simultaneously and in parallel at
many atomic, catalytic sites distributed across the surface of the
anode. Fuel cell performance is therefore determined not only by
the numeric efficiency of the oxidation reactions described in
Equation 3, but also by the number of catalytic sites available at
the anode (essentially determined by anode surface area) and by
the rate at which the reactions occur. One measure of fuel cell
performance is therefore the rate at which oxidation electrons are
collected (and driven through an external load), normalized to
anode surface area. Hence, it is customary to measure fuel cell
current (and power) area densities, and we characterize the
performance of our devices in these terms in Figures 8, 9, and 10.
Power output. We first characterize the glucose fuel cell
through a polarization curve, Figure 8, which shows the cell
potential (and corresponding output power density) maintained
while sourcing current at maximum transient rates. Using the fuel
cell as a current source by operating a potentiostat in controlled-
current mode, we drew current from the fuel cell at a rate
increasing from zero by 10 mAc m
22 s
22, until the cell potential
was abolished. Figure 8 shows the cell voltage and power output
generated during this procedure. The fuel cell generated an open-
circuit voltage of 192 mV, and transiently generated peak power
of more than 180 mWc m {2 when sourcing 1:5–1:85 mA cm{2.
Deep discharges at currents greater than 1:85 mA cm{2 for
longer than 10s were found to damage the fuel cells irreversibly.
Techniques that exploit resonant transformer action can be
used to efficiently convert even 20 mV energy-harvesting outputs
to 1–5Vlevels needed for powering electronic chips [38]. In an
actual brain– machine interface, such techniques will be needed to
increase the voltage level of our glucose fuel cell as well.
Impedance matching for optimizing power output. We
determined the steady-state power output of the glucose fuel cell
when driving a range of resistive loads. The results are shown in
Figure 9 for a 1 mm
2 device, which achieved maximum steady-
state power output of 3:4 mWc m {2 when driving a load of
550 kV. The curves shown with the data in Figure 9 represent the
output power density function
r~
V2
O
A
R
(RizR)
2 ð1Þ
Figure 4. Anode Roughening. These optical micrographs illustrate the effect of the roughening technique on the anode surface, showing the
atomically smooth platinum traces (narrow metallic strips) leading to the anode in contrast with the anode itself (large rectangular area). The
roughness of the anode surface is detectable optically as an abrupt change in color and texture. The image at right is an enlargement of the central
region of the image at left, focusing on the boundary between the smooth and rough platinum surfaces (rotated with the wire trace set vertical).
Scale: The wire traces (left and bottom left, respectively) are 100 mm wide.
doi:10.1371/journal.pone.0038436.g004
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anode area, 0:1|0:1c m 2; Ri denotes the inferred internal
resistance of the cell, 550kV; R denotes the variable load
resistance; and r denotes the output power density.
Power output as a function of glucose concentration. We
tested our fuel cells in standard 10mM phosphate buffered saline
(containing 138 mM NaCl, 2:7 mM KCl, 10 mM Na2
HPO4:2H2O, and 1:76 mM KH2PO4)a tpH 7:4 to simulate
Figure 5. Anode Micro- and Nanostructure. This set of scanning electron micrographs, taken of a fuel cell anode at increasing levels of
magnification (as indicated by the scale bars in each image), illustrates the effects of the roughening procedure on electrode surface structure overa
hierarchy of length scales from nanometers to micrometers.
doi:10.1371/journal.pone.0038436.g005
Figure 6. Nanostructural Effects of Surface Roughening. This pair of scanning electron micrographs, taken at the same level of magnification,
illustrates the effects of our surface roughening technique. The image at left is a high-magnification image of atomically smooth platinum deposited
by evaporation on silicon dioxide. The image at right is taken from one of our roughened anodes, and shows the highly porous nanostructure of the
electrode.
doi:10.1371/journal.pone.0038436.g006
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medium with glucose at various concentrations. The performance
data provided earlier in this section was obtained in the context of
10 mM glucose [39]. During testing we measured but did not
regulate system temperature, which ranged from 18uCt o2 4 uC.
As expected, and as quantified in Figure 10, the anodic current
generated by the fuel cell varies as a function of ambient glucose
concentration. Figure 10 shows the anodic current from a fuel cell
anode, derived through cyclic voltammetry, swept through
oxidizing potentials at 0:1Vs {1 while the anode was kept in
media containing glucose at concentrations from 0 to 40 mM.
Although physiologic concentrations are of primary interest in the
applications we discuss here, we have observed that oxidation
current continues to increase as a function of glucose concentra-
tion well beyond the upper limit of the normal physiologic range in
cerebrospinal fluid, approximately 4.4 mM. Figure 10 also
illustrates, in accord with the observations of others [40], that
concentration-dependent increases in oxidation current (reflected
by the areas of the glucose oxidation peaks in the region of 300 to
700 mV) are sublinear: oxidation current rises only slowly in
response to order-of-magnitude increases in glucose concentration.
The sublinearity of this relationship confirms that fuel cell
performance is not primarily substrate-limited at or near
physiologic glucose concentrations.
Methods
Solid-State Catalysis of Glucose Oxidation
The electrochemical reaction mechanisms of direct glucose fuel
cells are discussed in detail by Kerzenmacher and colleagues in
their thorough review of energy harvesting by implantable,
abiotically catalyzed glucose fuel cells [19]. The complete
oxidation of glucose to carbon dioxide and water is associated
with the transfer of 24 electrons per molecule of glucose, as
described by the reactions in Equation 2:
Anode : C6H12O6z24OH{?6CO2z18H2Oz24e{
Cathode : 6O2z12H2Oz24e{?24OH{
Overall : C6H12O6z6O2?6CO2z6H2O
DG0 : 2:870|106Jmol
{1
U0 : 1:24V
ð2Þ
However, studies have confirmed that glucose is not completely
oxidized when its oxidation is mediated by traditional, solid state
catalysts; the theoretical maximum rate of electron transfer from
glucose oxidation is not achieved in abiotically catalyzed glucose
fuel cells. Instead, glucose is principally oxidized to gluconolactone
in the reaction described by Equation 3, which transfers only a
single pair of electrons:
Figure 7. Atomic Force Microscopic Measurements of Anode Surface Roughness. Atomic force microscopic measurements of z-direction
(plane-normal) surface roughness at the 10 mm and 1 mm scales (upper and lower images, respectively), comparing atomically smooth platinum (left
images) with the roughened anodes we describe here (right images).
doi:10.1371/journal.pone.0038436.g007
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density (red, right axis) as functions of output current density. A 2 mm
2 device exhibits an open-cell voltage of 192 mV and achieves maximum
power output of more than 180 mWc m
22 when sourcing 1.5–1.85 mA cm
22.
doi:10.1371/journal.pone.0038436.g008
Figure 9. Impedance Matching to Maximize Output Power. Steady-state output power of the fuel cell exhibits characteristic second-order
dependence on the magnitude of the resistive load. A 1 mm
2 device achieves maximum steady-state power output of 3.4 mWc m
22 when driving a
load of 550 kV. (Blue curve, lower horizontal axis, linear scale; red curve, upper horizontal axis, logarithmic scale.).
doi:10.1371/journal.pone.0038436.g009
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Cathode :
1
2
O2zH2Oz2e{?2OH{
Overall : C6H12O6z
1
2
O2?C6H12O7
DG0 : 0:251|106Jmol
{1
U0 : 1:30V
ð3Þ
Gluconolactone is typically then hydrolyzed to form gluconic
acid. In principle, solid-state catalysts are capable of oxidizing
gluconolactone further, and high-pressure liquid chromatography
has detected tartaric and oxalic acids in such systems (resulting
from 14- and 22-electron-transfer processes, respectively), among
other oxidation products. In practice, the mean number of
electrons transferred per molecule of glucose oxidized depends on
the nature of the catalyst and on thermodynamic properties of the
system, such as ambient pH. Gebhardt and colleagues have shown
that the mean number of electrons transferred per molecule of
glucose by Raney-type catalysts can be up to 17 [27]. As this
family of high-surface-area catalysts has also been shown to
generate current densities an order of magnitude greater than
smooth noble metal catalysts, we chose to use Raney platinum
anodes to catalyze glucose oxidation in our fuel cells.
Separation of Anode and Cathode Reactions
Maintenance of a net potential difference between the anode
and the cathode of a fuel cell requires separation of the oxidation
and reduction half-reactions in a way that restricts each to only
one of the fuel cell electrodes. As discussed in [19] and elsewhere,
biologically implantable fuel cells pose a particular design
challenge in that the fuel (glucose) and the oxidant (oxygen) must
be extracted from same physiologic fluid, in which both are
dissolved. By contrast, fuel cells are traditionally configured so as
to isolate the anode from the cathode fluidically, in a compart-
mental arrangement that separates the two half-cell reactions.
The traditional configuration permits delivery of fuel to the
anode and oxidant to the cathode via separate fluidic channels, an
arrangement that can be effective because it physically prevents
reduction (typically of oxygen) from occurring at the anode, and
prevents oxidation of the fuel substrate from occurring at the
cathode. These reverse reactions cause electrochemical short
circuits by allowing both oxidation and reduction to occur at each
electrode, eliminating the net potential difference across the fuel
cell electrodes.
Preventing electrochemical short circuits in an implantable
glucose fuel cell requires a different approach to restricting the fuel
oxidation and oxygen reduction to the anode and cathode,
respectively. Several designs are reviewed in [19]. We have
adopted a modified version of a design first proposed by von
Sturm and colleagues [34,35], which uses an oxygen-selective
cathode catalyst to shield a nonselective anode from oxygen, while
allowing glucose to reach the anode without reacting at the
cathode. This scheme is illustrated in Figure 3.
As indicated in Figure 3, our fuel cell has a laminar structure: a
porous mesh of single-walled carbon nanotubes, embedded in
Nafion, comprises the cathode and forms the outermost layer; this
layer is followed (from the outside in) by a Nafion separator
membrane; a roughened (Raney-type) platinum anode; and finally
the impermeable, silicon dioxide substrate. In this configuration,
oxygen from the physiologic environment reacts at the carbon
cathode, resulting in a gradient in the oxygen concentration that
reaches its minimum, near zero, at the surface of the anode
[35,40]. The near absence of oxygen at the anode surface
minimizes the rate of oxygen reduction at the anode, which in turn
minimizes the electrochemical short-circuiting effects of such
reactions. On the other hand, because carbon does not catalyze
glucose oxidation, and because Nafion is permeable to glucose,
physiologic glucose passes through the pores in the nanotube mesh
unimpeded.
Figure 10. Oxidation Current Depends on Glucose Concentration. The oxidation current generated by the fuel cell anode, characterized here
via cyclic voltammetry, varies with glucose concentration.
doi:10.1371/journal.pone.0038436.g010
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In contrast with most previous work in the area of glucose fuel
cells [40], and in fulfillment of a recognized requirement for
advancement of the field [41,42], we manufactured our fuel cells
entirely within a Class 10 (ISO 4) cleanroom, using microfabrica-
tion techniques and processing standards that are completely
compatible with contemporary CMOS (complementary metalox-
idesemiconductor) integrated circuit manufacturing protocols. As a
result, the fabrication methods we describe here can be used to
enable wafer-level integration of fuel cell power sources with
electronic circuits and microfluidics, facilitating the development
of completely self-sufficient, embedded electronic and microfluidic
systems.
Substrates, masks, and lithography. Electrodes, separator
membranes, wire traces, and metal contacts were all patterned
using conventional photolithography, with transparency masks
printed to 2 mm feature-size tolerance (Infinite Graphics, Minne-
apolis, Minnesota). As substrates, we used 500 nm surface layers of
silicon dioxide on conventional, 150-millimeter-diameter (6-inch)
silicon wafers. To promote platinum adhesion, we deposited a
2 nm coat of titanium nitride on the oxide by evaporation.
Raney catalyst anode. We fabricated Raney-type, activated
platinum catalytic anodes using an approach similar to those
described by several other groups [27,43,44]. This technique
increases the catalytic capacity of a platinum electrode through
roughening, converting an atomically smooth layer of platinum
into a high-surface-area electrode. The overall approach involves
patterning a platinum-aluminum alloy, then etching the aluminum
out of the alloy to leave behind extremely porous platinum with a
nanostructure similar to that described by Attard and colleagues
[45,46]. Our implementation proceeded as follows. We patterned
all metal structures using a single mask, including the anode,
cathode contact ring, wire traces, and electrical contacts, as in
Figure 11, depositing 100 nm of platinum by evaporation. We
then deposited 100 nm of aluminum over the entire surface of the
wafer. Using a second mask, we patterned photoresist over the
regions designated for the anodes, protecting them from the
etchant acting in the following step: using tetramethylammonium
hydroxide (TMAH), we etched away the aluminum in all areas
except for those designated as anodes. After stripping the
remaining resist, we annealed the platinum and aluminum layers
at 300uC for 60 minutes. This anneal step generated a platinum-
aluminum alloy in the regions designated for the anodes. We then
repeated the aluminum etch step, this time without protecting the
anodes, in order to remove the aluminum from the alloy formed in
the anode regions. This second etch produces high-surface-area
Raney-type catalytic anodes, as shown in Figures 4, 5, 6, and 7,
and as discussed in the associated Methods subsections.
Nafion separator membrane and biocompatible
encapsulation layer. Several groups have reported difficulty
incorporating Nafion, a preferred ion-selective membrane in fuel
cell applications, into microfabrication processes. Patterning
Nafion lithographically does present some difficulties, as described
by Gold and colleagues [47] and others. Indeed, some groups have
recently proposed separation membranes composed of other
materials [48]. We used the following liftoff process for depositing
Nafion on silicon dioxide and platinum.
We selected the areas to be coated with Nafion by first coating
the wafers with 15–20 mm of photoresist (AZ 4620) and using a
third mask to pattern and expose the regions to be coated with
Nafion. We have found that using such thick layers of resist
facilitates proper Nafion patterning and liftoff by enabling
patterned regions of Nafion to be isolated in deep resist wells
formed at the wafer surface, following resist development and
evaporation of the Nafion dispersion solvent.
From a standard Nafion liquid dispersion (Nafion DE 521,
DuPont), we formed a 0.83% Nafion solution via 1:5 dilution in 2-
propanol. In a modified version of the protocol described in [49],
we used a spin-on process to coat our wafers with the resulting
dispersion, spinning the wafers at 750–1000 rpm for 3–10 s. In
order to cure the Nafion and facilitate bonding to the substrate
[50], we heated the wafers in a convection oven at 120uC for 20
minutes. This process generates Nafion layers approximately 60–
420 nm in thickness, as measured by spectroscopic ellipsometry
(Filmetrics, San Diego, California).
Carbon nanotube cathode. The cathode of our fuel cell
comprises a conducting mesh of single-walled carbon nanotubes
(swCNTs) embedded in Nafion, as shown in Figure 12, in
electrical contact with a platinum ring (the cathode contact) on the
wafer surface. This design is similar to the one described by Lee
and colleagues [51], and other groups have recently exploited
nanostructured carbon as a catalytic substrate in glucose fuel cells
[52]. The Nafion separator membrane electrically insulates the
cathode from the anode, while permitting cationic exchange. Both
the separator membrane and the cathode permit ambient glucose
to reach the anode surface: Nafion is inherently permeable to
glucose and the porosity of the swCNT mesh allows free transport
of glucose.
We constructed the Nafion-coated swCNT mesh by allowing it
to self-assemble. Using a procedure similar to the one described in
[53], we suspended previously synthesized and purified swCNTs
(Sigma-Aldrich Corporation) at a concentration of 8m gm L {1 in
an 0.83% Nafion dispersion of the kind described earlier in this
Methods Section, under ultrasonic agitation for 60 minutes. We
then patterned the Nafion-coated swCNT cathode using a fourth
lithographic mask, and spin-on and liftoff processes identical to
those described earlier in this Methods Section.
Models of Energy Harvesting from Glucose in the Brain
and Cerebrospinal Fluid
In this section we demonstrate that the cerebrospinal fluid is a
physiologic niche particularly well suited for an implanted fuel cell,
and we model the impact of an implanted glucose fuel cell on its
biological environment. In particular, we derive a model used to
determine the extent to which glucose and oxygen levels in the
cerebrospinal fluid permit energy harvesting without adverse
physiologic consequences.
Anatomy and composition of the cerebrospinal
fluid. The cerebrospinal fluid (CSF) comprises approximately
150 mL of fluid in the subarachnoid and intraventricular spaces,
respectively surrounding and filling hollow structures within the
human brain and spinal cord. The CSF is primarily produced by
modified ependymal cells of the choroid plexus, located within the
ventricles of the brain, as an ultrafiltrate of blood plasma whose
composition is also regulated through active transport.
Under normal conditions the CSF is acellular. Its normal
glucose content of 45–80 mg dL
21 (2.5–4.4 mM) [54] is compa-
rable to, albeit systematically approximately 2-fold lower than that
of plasma, which is normally regulated within the range of 70–
120 mg dL
21 (3.9–6.7 mM) [55]. By contrast, normal CSF
protein content is 15–45 mg dL
21 [56], which is at least 10
2-
fold lower than the normal range for plasma, 6000–8500 mg dL
21
[57]. The ionic composition of CSF resembles that of interstitial
fluid, and the two fluids are compared in Table 1.
With regard to the in vitro testing conditions for our glucose fuel
cell, it is worth noting that a number of formulations for artificial
cerebrospinal fluid (aCSF) have been described and developed in
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nents and gas partial pressures), both for experimental purposes
[39] and in order to replace CSF lost during neurosurgical
procedures [56]. In clinical practice, however, normal saline is
routinely used during neurosurgery to replace CSF.
Availability and use of glucose in the cerebrospinal
fluid. At physiologic glucose concentrations, high-efficiency
biofuel cells such as the microbial biofuel cells developed by
Rabaey and colleagues convert glucose to electricity with
Coulombic efficiency exceeding gC~80% [58], and Lovley and
colleagues have reported such efficiencies even at lower glucose
concentrations [59]. At the opposite, low-efficiency extreme,
abiotically catalyzed biofuel cells typically oxidize glucose incom-
pletely to products such as gluconic acid, yielding only two
electrons compared with the theoretical maximum of twenty-four
electrons per molecule of glucose [19], corresponding to a
maximum Coulombic efficiency of only approximately gC~8%.
The minimum glucose flux, Jg, required to fuel a glucose fuel cell
generating power P,i s
Jg~
P
gDGg
ð4Þ
where g reflects the overall efficiency of the system (the Coulombic
efficiency provides an upper bound on the overall efficiency), and
DGg ~ 2880Jmol
{1 denotes the heat of combustion of glucose.
Using Equation 4, we can estimate the minimal glucose flux
(amount of glucose per day) required to power a fuel cell
generating P ~ 1m W :
Jg~
1m W ðÞ | 86400 seconds per day ðÞ
0:08{0:80 efficiency ðÞ | 2880 kJ per completely oxidized mole glucose ðÞ
180 grams per mole glucose
ð5Þ
~6:7567:5 mg (37:5{375 mmol) glucose per day ð6Þ
Figure 11. Photolithography Masks and Fabricated Fuel Cells. The image at left shows a set of superimposed photolithographic masks for
glucose fuel cells of various sizes, arranged for fabrication on a silicon wafer 150 mm (6 inches) in diameter. The largest device depicted has an anode
that measures 64 mm by 64 mm. The anodes of the other fuel cells shown are scaled-down versions of the large device, with length and width
alternately reduced by factors of two. The schematic was constructed by overlaying the four process layers: yellow, platinum; orange, roughened
platinum anode (aluminum deposition for annealing); blue, Nafion; green, cathode (single-walled carbon nanotubes in Nafion). The photograph at
right shows the corresponding silicon wafer as fabricated. Scale Bar: 2 cm.
doi:10.1371/journal.pone.0038436.g011
Figure 12. Fuel Cell Cathode. Scanning electron micrograph of the
fuel cell cathode, showing the conducting mesh of carbon nanotubes
encapsulated in Nafion ionomer. Scale Bar: 1 mm.
doi:10.1371/journal.pone.0038436.g012
Table 1. Ionic Composition of Cerebrospinal Fluid and
Interstitial Fluid.
Species CSF Concentration ISF Concentration
Na
+ 154 mM 146 mM
K
+ 3.0 mM 4.1 mM
Cl
– 128 mM 118 mM
{
3 HCO 23 mM 22 mM
H
+ pH<7.34 pH<7.44
Typical values for the principal ionic constituents of mammalian cerebrospinal
and interstitial fluids [64].
doi:10.1371/journal.pone.0038436.t001
(5)
(5)
(6)
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should not be mistaken for minus signs.) Since cerebrospinal fluid
in a typical adult human is produced at a rate of approximately
gf ~ 550mL per day [60], the total flow of glucose through the
subarachnoid space is approximately 250–440 mg per day. Thus,
a biofuel cell in the configuration we propose consumes glucose at
a rate of at most 2.8–28% of the rate at which cerebrospinal fluid
glucose is replenished; by comparison, physiologic fluctuations in
cerebrospinal fluid glucose can exceed 25%. So availability of
glucose is not likely to be a limiting factor and glucose usage by a
biofuel cell of the kind we describe here should not interfere with
normal physiologic processes. (At low glucose utilization efficien-
cies a more accurate model of CSF bulk flow might be required
before this model can be considered sufficient, as the fraction of
the total glucose flux available to a fuel cell as a result of CSF bulk
flow will depend on the precise location of the fuel cell within the
subarachnoid space.).
Availability and use of oxygen in the cerebrospinal
fluid. Typical oxygen partial pressures in human cerebrospinal
fluid are 25–50 mmHg [61]. These levels correspond to 35–
70 mmol L
21 or 1.1–2.2 mg L
21 if, as in [62], the solubility
coefficient a of cerebrospinal fluid is considered equal to that of
plasma (a ~ 0:003mLO2 dL{1 mmHg{1~ 1:4 mmolO2 L{1
CSF
mmHg{1). The bulk flow of oxygen through the subarachnoid
space is therefore approximately JO2 ~ 19{38 mmol per day~
223{446 pmol s{1. So physiologic oxygen levels are comparable
to (slightly lower than) those under which biofuel cells such as
those of Rabaey and colleagues have been tested. The electro-
reduction reactions of oxygen to water accompanying complete
oxidation of glucose require ag?O2~6 moles of oxygen per mole
of glucose, so the oxygen consumption rate, JO2, in the system we
propose would be approximately
JO2~ag?O2Jg ð7Þ
~
(1 mW)
(0:08{0:80 efficiency)|(2880 kJ per completely oxidized mole glucose)
(6 moles O2 per completely oxidized mole glucose)
ð8Þ
~225{2250 mmol O2 perday (2:6{26 nmol O2s{1) ð9Þ
Thus, a biofuel cell in the configuration we propose consumes
oxygen at a rate of 6–12 times the rate at which oxygen is
replenished by cerebrospinal fluid bulk flow when operating at
80% efficiency, and ten times those rates when operating at 8%
efficiency. Cerebrospinal fluid oxygen equilibrium under these
conditions therefore depends on the ability of oxygen concentra-
tions in cerebrospinal fluid and brain tissue interstitium to
equilibrate through oxygen diffusion. A brain-implanted biofuel
cell would exploit this equilibrating mechanism as a natural analog
to continuous aeration of the cathode compartments of some
laboratory-built biofuel cells. The diffusional transport character-
istics of oxygen are such that equilibrium can be maintained with
only a negligible perturbation to cerebrospinal fluid and interstitial
oxygen concentrations, as the following calculations demonstrate.
As Lu and colleagues describe mathematically [62], the oxygen
concentration C in the cerebrospinal fluid normally depends on
four factors: (1) The oxygen partial pressure Pc in the choroid
plexus capillaries, whose content is filtered and transported
through the choroid ependymal cells to become cerebrospinal
fluid; (2) The oxygen partial pressure Pi within the brain tissue
interstitial fluid; (3) The formation rate gf of cerebrospinal fluid;
and (4) The drainage rate gd of cerebrospinal fluid. Under normal
conditions gf~gd:g&550 mL per day~ 6:4 mLs{1. Oxygen
partial pressures in blood plasma, interstitial fluid, and cerebro-
spinal fluid are proportional to oxygen concentrations through
solubility coefficients that have approximately the same value for
all three fluids: a&1:4 mmolO2 L{1 mmHg{1. In the presence of
a biofuel cell of the kind described here, the oxygen concentration
also depends on a fifth factor: (5) The rate JO2 at which the biofuel
cell consumes oxygen. The rate of change of the concentration of
oxygen in cerebrospinal fluid can therefore be expressed by the
following equation:
dC
dt
~
1
VCSF
gfaPc{gdCzDP i{
C
a
  
{JO2
  
ð10Þ
where VCSF&150 mL denotes the total volume of cerebrospinal
fluid in the subarachnoid space, and D~17 mmol mmHg{1 s{1
is the diffusion capacity of oxygen between the interstitial fluid and
the cerebrospinal fluid [62]. The five terms within the curly braces
can be understood as follows: (1) The concentration C increases as
oxygen flows into the cerebrospinal fluid from the choroid plexus
capillaries at a rate proportional to gf and concentration aPc,
hence the term gfaPc; (2) The concentration C decreases as
oxygen flows out of the cerebrospinal fluid at rate proportional to
gd and concentration C, hence the term gdC; (3&4) Oxygen
diffuses into the cerebrospinal fluid from the interstitial fluid in
proportion to the partial pressure gradient between the interstitial
fluid (at oxygen partial pressure Pi) and the cerebrospinal fluid (at
oxygen partial pressure Pc~
C
a
), with a proportionality constant of
D, the diffusion capacity; (5) Oxygen is consumed by the biofuel
cell at rate JO2. When the oxygen concentration C is at steady
state, its rate of change vanishes, allowing us to solve for the
equilibrium oxygen concentration, Ceq:
Ceq~
gaPczDPi{JO2
gz
D
a
ð11Þ
&
DPi{JO2
D
a
ð12Þ
where the approximation holds because the diffusion transport is
much faster than the bulk flow transport, allowing us to neglect the
bulk flow terms containing g (g~6:4 mLs {1 is six orders of
magnitude smaller than
D
a
~12 L s{1; and since Pc and Pi are on
the same order of magnitude, gaPc is six orders smaller than DPi).
Equation 11 permits us to compare the equilibrium concentrations
of oxygen in the cerebrospinal fluid in the presence
(JO2~2:6{26 nmol s{1) and absence (JO2~0) of the biofuel cell:
DCeq
Ceq
~
Cpresent
eq {Cabsent
eq
Cabsent
eq
ð13Þ
~{
JO2
DPi
ð14Þ
(8)
(9)
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({2:6{26 nmols{1)
(17 mmol mmHg{1 s{1)|(40 mmHg)
ð15Þ
~{3:838|10{6 ð16Þ
Thus, the fractional change in oxygen concentration in the cerebrospinal
fluid due to the presence of the biofuel cell will only be a few parts per million.
(The precise value of the interstitial pressure, approximated here
as 40 mmHg, does not greatly impact this result). Note that
although oxygen consumption by the biofuel cell will draw oxygen
out of brain tissue into the cerebrospinal fluid, the corresponding
decrease in interstitial fluid oxygen concentration will be even
smaller in magnitude than the decrease in the cerebrospinal fluid,
since the intracranial interstitial fluid volume is approximately
twice that of the cerebrospinal fluid [62].
Oxygen equilibration time in cerebrospinal fluid. We
can also estimate the time scale over which oxygen concentrations
equilibrate in the cerebrospinal fluid. The system modeled by
Equation 10 exhibits first-order kinetics with a time constant t
given by
t~
VCSF
gz
D
a
ð17Þ
&
VCSF
D
a
ð18Þ
~
0:150 L
12 L s{1 ð19Þ
~12:5m s ð20Þ
So the oxygen concentrations in this system equilibrate on the
rapid timescale of tens of milliseconds.
Structure of oxygen concentration gradients in
cerebrospinal fluid due to fuel cell oxygen uptake. To
demonstrate that the surface-area-to-volume characteristics of our
proposed brain-implanted biofuel cell are consistent with a
functioning system, we can model the approximate structure of
the concentration gradient field around the cathode. In a first-
order approximation, the concentration of oxygen will approxi-
mately vanish at the surface of the cathode, where oxygen is
electroreduced to water; and at a certain distance d (which we will
determine) from the surface the concentration will be equal to C,
the average oxygen concentration of the cerebrospinal fluid. If d is
much smaller than the characteristic dimension
ﬃﬃﬃﬃ
A
p
of the cathode
(where A denotes the cathode area) and also much smaller than the
width of the subarachnoid space at any location, the oxygen
concentration C ~ x x ðÞ as a function of position will be approximately
Cpresent
eq everywhere except within a region close to the cathode
surface; within that region the concentration satisfies C ~ x x~0 ðÞ ~0
at the cathode surface, and rises to C ~ x x~^ e e\d ðÞ ~Cpresent
eq at a
distance d normal to the cathode surface.
We can demonstrate that the diffusion characteristics of oxygen
in the cerebrospinal fluid set d to a value consistent with efficient
fuel cell operation in a brain-implanted system. We have
demonstrated that the average concentration of oxygen in the
cerebrospinal fluid equilibrates rapidly to Cpresent
eq when the fuel
cell is operating, so the spatial distribution C ~ x x ðÞis effectively
constant at times more than several t (several tens to hundreds of
milliseconds) after the biofuel cell is turned on. We can therefore
use Fick’s First Law of Diffusion to determine d:
J~{DCSF+\C ~ x x ðÞ ð 21Þ
{
JO2
A
&{DCSF
C
eq
present{0
d
ð22Þ
where the first equation is a statement of Fick’s First Law for our
system, and the second line expresses the first-order approximation
we just described. The parameter DCSF&3|10{5 cm
2 s
21 is the
diffusion coefficient of oxygen in cerebrospinal fluid (approxi-
mately equal to that in water), J~
JO2
A is the oxygen flux (here
defined as an area-normalized flow) near the surface of the
cathode, and +\C ~ x x ðÞ &
DC
d
&
C
eq
present{0
d
is the oxygen concen-
tration gradient near the cathode surface (linearized in this first-
order approximation). Therefore,
d~DCSF
Cpresent
eq
JO2
A ð23Þ
so if the physiologic range of C is 35–70 mmol l21, d can be at
most
d~
(3|10{5 cm2 s{1)|(70 mmol L{1)|(10{3 Lcm {3)
(2:6 nmols
{1)
|(10 cm2)
ð24Þ
~80 mm ð25Þ
for a device with surface area as great as A=10cm
2. The value
d=80mm satisfies our requirements that the concentration
gradient vanish over a length scale much smaller than the typical
dimension of the cathode and much smaller than the smallest
width of the subarachnoid space, but it is also large enough to be
physically achievable, as it is orders of magnitude larger than the
mean free path of an oxygen molecule in water [63]. Thus, oxygen
diffusion to the cathode in the system we propose will not be
limited by the geometry of the system.
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